Shilei DING

PhD

Research associate,  Immunopathology
Shilei DING

Contact

Phone: 514-890-8000, ext. 24308

Email: shilei.ding@mail.mcgill.ca

Publications

If you need medical assistance, you MUST NOT contact the researcher directly. For immediate assistance, call 811 or 911.

Job

Specialist Experimental imaging core facility, CRCHUM

Research Interests

  1. Research on HIV envelope glycoprotein (Env): Small-molecule CD4 mimetics (CD4mc) such as BNM-III-170 and MCG-IV-210 sensitize HIV-1-infected cells to antibody-dependent cellular cytotoxicity (ADCC) mediated by non-neutralizing-Abs (nnAbs) present in plasma from people living with HIV (PLWH). We are optimizing MCG-IV-210 analogs that can gain breadth and ADCC activity;
  2. Develop compounds for the treatment of SARS-CoV-2 infection:  Small molecule VE607 is a broadly inhibitor for major SARS-CoV-2 variants of concern (VOCs). We found that it binds to the receptor binding domain (RBD)-ACE2 interface and stabilizes RBD in its “up” conformation. VE607 derived analogs will be tested to improve the in vivo efficacy;
  3. Build up procedures for utilizing replicating authentic SARS-CoV-2 viruses: test neutralization or ADCC with Abs or compounds using replicating authentic SARS-CoV-2 variant viruses infected cells.     

Expertises

Researcher in charge

News

Immunopathology

The Immunopathology Research Theme comprises a group of researchers spanning the basic and clinical research continuum and focusing on the immune/inflammatory processes involved in the disturbance and restoration of homeostasis. These activities are rooted in shared visions regarding explorat…

Learn more
Manipulations de laboratoire
CHUM

Researchers from this theme

See all researchers
Make a donation